Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > REDX IMMUNOLOGY LIMITED
Company Information for

REDX IMMUNOLOGY LIMITED

BLOCK 33 MERESIDE, ALDERLEY PARK, MACCLESFIELD, SK10 4TG,
Company Registration Number
09000503
Private Limited Company
Active

Company Overview

About Redx Immunology Ltd
REDX IMMUNOLOGY LIMITED was founded on 2014-04-16 and has its registered office in Macclesfield. The organisation's status is listed as "Active". Redx Immunology Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as FULL
  • Annual turnover is £6.5 million or more
  • The balance sheet total is £ 3.26 million or more
  • Employs 50 or more employees
  • May be publically listed
  • May be a member of a group of companies meeting any of the above criteria
Key Data
Company Name
REDX IMMUNOLOGY LIMITED
 
Legal Registered Office
BLOCK 33 MERESIDE
ALDERLEY PARK
MACCLESFIELD
SK10 4TG
Other companies in M2
 
Previous Names
REDX METABOLIC LIMITED23/12/2014
Filing Information
Company Number 09000503
Company ID Number 09000503
Date formed 2014-04-16
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 30/09/2023
Account next due 30/06/2025
Latest return 16/04/2016
Return next due 14/05/2017
Type of accounts FULL
Last Datalog update: 2024-05-05 15:42:06
Primary Source:Companies House
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of REDX IMMUNOLOGY LIMITED

Current Directors
Officer Role Date Appointed
DOMINIC NICHOLAS JACKSON
Director 2018-02-07
IAIN GLADSTONE ROSS
Director 2017-11-03
Previous Officers
Officer Role Date Appointed Date Resigned
NEIL DAVID MURRAY
Director 2015-08-27 2017-11-03
PHILIP JOHN TOTTEY
Director 2015-08-27 2016-09-30
DEREK LINDSAY
Director 2015-08-27 2016-05-06
NORMAN MOLYNEUX
Director 2014-04-16 2015-08-27

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
DOMINIC NICHOLAS JACKSON REDX ONCOLOGY LTD Director 2018-02-07 CURRENT 2011-12-05 Active
DOMINIC NICHOLAS JACKSON REDX ANTI-INFECTIVES LTD Director 2018-02-07 CURRENT 2012-07-09 Liquidation
DOMINIC NICHOLAS JACKSON REDX PHARMA LIMITED Director 2017-11-03 CURRENT 2010-09-07 Active
DOMINIC NICHOLAS JACKSON GIELEN PARTNERS LIMITED Director 2013-10-24 CURRENT 2013-10-24 Liquidation
IAIN GLADSTONE ROSS REDX ONCOLOGY LTD Director 2017-11-03 CURRENT 2011-12-05 Active
IAIN GLADSTONE ROSS REDX ANTI-INFECTIVES LTD Director 2017-11-03 CURRENT 2012-07-09 Liquidation
IAIN GLADSTONE ROSS REDX MRSA LIMITED Director 2017-11-03 CURRENT 2014-09-04 Liquidation
IAIN GLADSTONE ROSS REDX PHARMA LIMITED Director 2017-05-01 CURRENT 2010-09-07 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-12-16Change of details for Redx Pharma Plc as a person with significant control on 2024-05-09
2024-04-24CONFIRMATION STATEMENT MADE ON 16/04/24, WITH UPDATES
2024-04-05FULL ACCOUNTS MADE UP TO 30/09/23
2023-04-19CONFIRMATION STATEMENT MADE ON 16/04/23, WITH UPDATES
2023-03-22FULL ACCOUNTS MADE UP TO 30/09/22
2023-03-22FULL ACCOUNTS MADE UP TO 30/09/22
2022-09-01Appointment of Claire Penelope Solk as company secretary on 2022-09-01
2022-07-07AAFULL ACCOUNTS MADE UP TO 30/09/21
2022-04-21CS01CONFIRMATION STATEMENT MADE ON 16/04/22, WITH UPDATES
2021-06-09AUDAUDITOR'S RESIGNATION
2021-06-03TM01APPOINTMENT TERMINATED, DIRECTOR IAIN GLADSTONE ROSS
2021-04-20AAFULL ACCOUNTS MADE UP TO 30/09/20
2021-04-16CS01CONFIRMATION STATEMENT MADE ON 16/04/21, WITH UPDATES
2020-08-10MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 090005030002
2020-08-07MR01REGISTRATION OF A CHARGE / CHARGE CODE 090005030003
2020-07-13MEM/ARTSARTICLES OF ASSOCIATION
2020-07-13RES13Resolutions passed:
  • Company to enter into transaction documents / directors authorised to approve terms of transactions 29/06/2020
  • ALTER ARTICLES
2020-06-02AAFULL ACCOUNTS MADE UP TO 30/09/19
2020-04-30RP04PSC02Second filing of notification of person of significant controlRedx Immunology Plc
2020-04-23CS01CONFIRMATION STATEMENT MADE ON 16/04/20, WITH UPDATES
2020-04-21RES01ADOPT ARTICLES 21/04/20
2020-04-07MEM/ARTSARTICLES OF ASSOCIATION
2020-03-30MR01REGISTRATION OF A CHARGE / CHARGE CODE 090005030002
2020-02-28PSC02Notification of Redx Pharma Plc as a person with significant control on 2017-06-26
2020-02-27PSC07CESSATION OF NEIL DAVID MURRAY AS A PERSON OF SIGNIFICANT CONTROL
2020-02-10AP01DIRECTOR APPOINTED LISA MARY WHEWELL ANSON
2020-01-24MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 090005030001
2019-07-02MEM/ARTSARTICLES OF ASSOCIATION
2019-07-02RES13Resolutions passed:
  • Transaction documents 07/06/2019
  • ALTER ARTICLES
2019-06-12MR01REGISTRATION OF A CHARGE / CHARGE CODE 090005030001
2019-04-25CS01CONFIRMATION STATEMENT MADE ON 16/04/19, WITH UPDATES
2019-03-22AP01DIRECTOR APPOINTED DR JAMES ROBERT MEAD
2019-03-20AASMALL COMPANY ACCOUNTS MADE UP TO 30/09/18
2019-03-05TM01APPOINTMENT TERMINATED, DIRECTOR DOMINIC NICHOLAS JACKSON
2018-04-19LATEST SOC19/04/18 STATEMENT OF CAPITAL;GBP .01
2018-04-19CS01CONFIRMATION STATEMENT MADE ON 16/04/18, WITH UPDATES
2018-03-15AAFULL ACCOUNTS MADE UP TO 30/09/17
2018-03-05AP01DIRECTOR APPOINTED MR DOMINIC NICHOLAS JACKSON
2017-11-07TM01APPOINTMENT TERMINATED, DIRECTOR NEIL DAVID MURRAY
2017-11-07AP01DIRECTOR APPOINTED MR IAIN GLADSTONE ROSS
2017-09-04AD01REGISTERED OFFICE CHANGED ON 04/09/17 FROM C/O Acceleris Capital Limited 9th Floor Lowry House 17 Marble Street Manchester M2 3AW
2017-05-30AAFULL ACCOUNTS MADE UP TO 30/09/16
2017-04-25LATEST SOC25/04/17 STATEMENT OF CAPITAL;GBP .01
2017-04-25LATEST SOC25/04/17 STATEMENT OF CAPITAL;GBP .01
2017-04-25CS01CONFIRMATION STATEMENT MADE ON 16/04/17, WITH UPDATES
2017-04-25CS01CONFIRMATION STATEMENT MADE ON 16/04/17, WITH UPDATES
2016-10-04TM01APPOINTMENT TERMINATED, DIRECTOR PHILIP JOHN TOTTEY
2016-07-20TM01APPOINTMENT TERMINATED, DIRECTOR DEREK LINDSAY
2016-05-10LATEST SOC10/05/16 STATEMENT OF CAPITAL;GBP .01
2016-05-10AR0116/04/16 ANNUAL RETURN FULL LIST
2016-02-08AAFULL ACCOUNTS MADE UP TO 30/09/15
2015-08-27AP01DIRECTOR APPOINTED MR PHILIP TOTTEY
2015-08-27AP01DIRECTOR APPOINTED MR NEIL MURRAY
2015-08-27AP01DIRECTOR APPOINTED MR DEREK LINDSAY
2015-08-27TM01APPOINTMENT TERMINATED, DIRECTOR NORMAN MOLYNEUX
2015-04-28LATEST SOC28/04/15 STATEMENT OF CAPITAL;GBP .01
2015-04-28AR0116/04/15 ANNUAL RETURN FULL LIST
2015-04-14AA01Current accounting period extended from 30/04/15 TO 30/09/15
2014-12-23RES15CHANGE OF NAME 16/12/2014
2014-12-23CERTNMCompany name changed redx metabolic LIMITED\certificate issued on 23/12/14
2014-04-16LATEST SOC16/04/14 STATEMENT OF CAPITAL;GBP .01
2014-04-16NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
2014-04-16MODEL ARTICLESMODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to REDX IMMUNOLOGY LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against REDX IMMUNOLOGY LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 3
Mortgages/Charges outstanding 1
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 2
Details of Mortgagee Charges
We do not yet have the details of REDX IMMUNOLOGY LIMITED's previous or outstanding mortgage charges.
Intangible Assets
Patents
We have not found any records of REDX IMMUNOLOGY LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for REDX IMMUNOLOGY LIMITED
Trademarks
We have not found any records of REDX IMMUNOLOGY LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for REDX IMMUNOLOGY LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as REDX IMMUNOLOGY LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where REDX IMMUNOLOGY LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded REDX IMMUNOLOGY LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded REDX IMMUNOLOGY LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.